# GeneDock

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genedock

- Industry: Software
- Headquarters: Beijing, China
- Website: www.genedock.com
- Latest round: Series B (Jul 17, 2018)
- Investors on record: 7

## About

GeneDock is a technology company that specializes in offering innovative software solutions aimed at improving operational efficiency across various business sectors.Founded in 2014 and headquartered in Beijing, China, GeneDock provides advanced software solutions that enhance business operations. The company has undergone strategic developments but remains focused on providing tech solutions tailored for various industries. Xiarong Li serves as the CEO, and the company has successfully completed 3 deals, with the latest funding round being a Series B in July 2018.GeneDock specializes in providing innovative technology solutions, primarily centered around its flagship product, a software platform designed to enhance operational efficiency for businesses across various sectors. This platform integrates advanced data analytics and automation tools, enabling clients to streamline processes, reduce costs, and improve decision-making capabilities. The end users, ranging from small businesses to large enterprises, leverage these solutions to address challenges such as resource allocation, data management, and workflow optimization. Launched in 2021, the software has been adopted across diverse industries, including healthcare, finance, and retail, with a growing customer base located in North America, Europe, and Asia-Pacific markets. The company's commitment to continuous improvement and customer-centric development ensures that its offerings evolve to meet the dynamic needs of its clientele.GeneDock's revenue model is structured around a subscription-based framework, allowing clients to access its software platform through tiered pricing plans that cater to varying organizational needs. Clients typically enter into annual contracts that provide them with ongoing updates, customer support, and additional features as they become available. Revenue is generated primarily through direct sales to businesses, with options for partnerships that enhance service delivery and market reach. The structure includes both B2B transactions and direct-to-consumer sales, with clients paying for their chosen level of service which may include premium features and custom integrations. The company's revenue growth is supported by its strategic pricing strategies and a focus on customer acquisition within key geographical markets.GeneDock aims to enhance its offerings with new product developments set for release in the coming years. The company is also planning to expand into North American and European markets by the end of 2023. The Series B funding raised in July 2018 will be allocated towards these new product developments and market expansions, supporting ongoing growth and innovation.

## Funding rounds

- Series B, Jul 17, 2018 — 5Y Capital, Shenzhen Huada Gene Technology Co., Ltd., Baidu Ventures, Furong Capital
- Series A, Jan 20, 2017 — Legend Star, Puhua Capital
- Angel, Aug 20, 2015 — MPC

## Investors

- MPC — Angel
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series A
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series B
- Shenzhen Huada Gene Technology Co., Ltd. — Series B
- Baidu Ventures (https://capitalatlas.ai/funds/baidu-ventures) — Series B
- Furong Capital (https://capitalatlas.ai/funds/furong-capital) — Series B